Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65 (RelA)

Journal of Cell Biology

Volumn 139, Issue 7, 1997, Pages 1635-1643

  Ferrari, Davide ^a   Wesselborg, Sebastian ^a   Bauer, Manuel K A ^a   Schulze Osthoff, Klaus ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Medical Clinic Tubingen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NUCLEOTIDE; PROTEINASE; PROTEINASE INHIBITOR; PURINE RECEPTOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL MEMBRANE; CHANNEL GATING; DNA BINDING; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; IMMUNITY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CASPASE 1; CELL LINE; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; INTERLEUKIN-1; KINETICS; MICE; MICROGLIA; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0031425953     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.7.1635     Document Type: Article

References (59)

1. Baeuerle, P.A., and T. Henkel. 1994. Function and activiation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
2. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
3. Baichwal, V.R., and P.A. Baeuerle. 1997. Activate NF-κB or die? Curr. Biol. 7:R94-R96.
4. Baldwin, A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 242:540-546.
5. Bauer, M.K.A., K. Lieb, K. Schulze-Osthoff, J. Bauer, P.J. Gebicke-Haerter, and B.I. Fiebich. 1997. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243:726-731.
6. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:782-784.
7. Boland, M.P., S.J. Foster, and L.A. O'Neill. 1997. Daunorubicin activates NF-κB and induces κB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphama cells. J. Biol. Chem. 272:12952-12960.
8. Burnstock, G., and J.N. Wood. 1996. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Cell Biol. 6:526-532.
9. 1, in thymocyte apoptosis. Immunity. 5:275-283.
10. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
11. Das, W., and C. W. White. 1997. Activation of NF-κB by antineoplastic agents. Role of protein kinase C. J. Biol. Chem. 272:14914-14920.
12. DiDonato, J.A., M. Hayakawa, D. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:548-554.
13. Di Virgilio, F. 1995. The purinergic P2Z receptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 16:524-528.
14. Dubyak, G.R., and C. El-Moatassim. 1993. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265:C577-C606.
15. 2Z receptor of human macrophage cells: characterization and possible physiological role. J. Clin. Invest. 95:1207-1216.
16. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activity and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:726-731.
17. Ferrari, D., M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156:1531-1539.
18. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, G. Collo, G. Buell, and F. Di Virgilio. 1997. ATP-mediated cytotoxicity in microglial cells. J. Neuropharmacol. 36:1295-1301.
19. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185:579-582.
20. Fredholm, B.B., M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacohson, P. Leff, and M. Williams. 1994. Nomenclature and classification of purinoreceptors. Pharmacol. Rev. 46:143-156.
21. Gehrmann, J., Y. Matsumoto, and G.W. Kreutzberg. 1996. Microglia: intrinsic immune effector cells of the brain. Brain Res. Rev. 20:269-287
22. Griffith, R.J., E.J. Stam, J.T. Downs, and I.G. Otterness. 1995. AIP induces the release of IL-1 from LPS-primed cells in vivo. J. Immunol. 154: 2821-2828.
23. Grilli, M., M. Pizzi, M. Memo, and P.F. Spano. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science. 274:1383-1385.
24. Grimm, S., M. Bauer, P.A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 attenuates the activity of NF-κB which is induced upon apoptosis. J. Cell Biol. 134:13-23.
25. Hogquist, K.A., M.A. Nett, E.R. Unanue, and D.D. Chaplin. 1991. Interleukin-1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA. 88:8485-8489.
26. 4+ T lymphocytes. Science. 256:1452-1456.
27. Kumar, S., and N.L. Harvey. 1995. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375:169-173.
28. Kunsch, C., and C.A. Rosen. 1993. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13:6137-6146.
29. Kunsch, C.A., S.M. Ruben, and C.A. Rosen. 1992. Selection of optimal κB/ Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
30. Lin, K.-I., S.-H, Lee, R. Narayanan, J.M. Baraban, J.M. Hardwick, and R.R. Ratan. 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131:1149-1161.
31. Los, M., H. Schenk, K. Hexel, P.A. Baeuerle, W. Droge, and K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14: 3731-3740.
32. Los, M., M. Van deCraen, L.C. Penning, H. Schenk, M. Westendorp, P.A. Baeuerle, W. Droge, P.H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/Ced-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:81-83.
33. Murgia, M., S. Hanau, P. Pizzo, M. Rippa, and F. Di Virgilio. 1993. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268:8199-8203.
34. Nicholson, D.N., and N.A. Thornberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299-306.
35. 2+ and reactive oxygen intermediates. FEBS Lett. 392: 129-136.
36. 7. Cloning and expression of a human cDNA. J. Biol. Chem. 272:5482-5486.
37. Regnier, C.H., H.Y. Song, X. Gao, D.V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell. 90:373-383.
38. Righi, M., L. Mori, G. De Libero, M. Sironi, A. Biondi, A. Mantovani, S. Denis-Donini, and P. Ricciardi-Castagnoli. 1989. Monokine production by microglial cells. Eur. J. Immunol. 19:1443-1448.
39. Sadoul, R., P.-A. Fernandez, A.-L. Quiquerez, I. Martinou, M. Maki, M. Schröter, J.D. Becherer, M. Irmler, J. Tschopp, and J.-C. Martinou. 1996. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15:3845-3852.
40. Schenk, H., M. Klein, W. Erdbrügger, W. Dröge, and K. Schulze-Osthoff. 1994. Distinct effects of thioredoxin and other antioxidants on the activation of NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 91:1672-1676.
41. Schmidt, K.N., P. Amstad, P. Cerutti, and P.A. Baeuerle. 1993. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem. Biol. 2:13-22.
42. Schreck, R., P. Rieber, and P.A. Baeuerle. 1991. Reactive oxygen intemediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247-2258.
43. Schulze-Osthoff, K., M. Bauer, M. Vogt, and M. Los. 1996. Role of ICE-related and other proteases in Fas-mediated apoptosis. Cell Death Diff. 3:177-184.
44. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:3095-3104.
45. Schube-Osthoff, K., M. Los, and P.A. Baeuerle. 1995. Redox regulation of transcription factor NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735-741.
46. 7). Science. 272:735-738.
47. Takeuchi, M., and V.R. Baichwal. 1995. Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor α is mediated by NF-κB proteins. Proc. Natl. Acad. Sci. USA. 92: 3561-3565.
48. Thompson, J.E., R.J. Phillips, H. Erdjumant-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:573-582.
49. Thornberry, N.A., H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux, J.R. Weidner, and J. Aunins. 1992. A novel heterodimeric cysteine protease is required tor interleukin-1β processing in monocytes. Nature. 356:768-774.
50. Traenckner, E.B.-M., S. Wilk, and P.A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:433-3441.
51. van Antwerp, D.J., S.J. Martin, T. Kafri, D. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787-789.
52. 2 heterodimer. Cell. 78:343-352.
53. Wang, C.-Y., M.W. Mayo, and A.S. Jr. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-787.
54. White, D.W., and T.D. Gilmore. 1996. Bcl-2 and CrmA have different effects on transformation, apoptosis, and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene. 13:891-899.
55. Whiteside, S.T., J.-C. Epinat, N.R. Rice, and A. Israel. 1997. IκBε, a novel member of the IκB family, controls RelA and c-Rel NFκB binding activity. EMBO J. 16:1413-1426.
56. Wilson, K.P., R. Black, J.A. Thomson, E.E, Kim, J.P. Griffith, M.A. Navia, M.A. Murcko, S.P. Chambers, R.A. Aldape, S.A. Raybuck, and D.J. Livingston. 1994. Structure and mechanism of interleukm-1β converting enzyme. Nature. 370:270-275.
57. Zabel, U., and P.A. Baeuerle. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell. 61:255-265.
58. Zanovello, P., V. Bronte, A. Rosato, P. Pizzo, and F. Di Virgilio. 1990. Resenses of mouse lymphocyles to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J. Immunol. 145:1545-1550.
59. Zimmermann, H. 1994. Signaling via ATP in the nervous system. Trends Neurosci. 17:420-426.